Merck | Patient Daily

Merck

Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'

Press release submission | Sep 23, 2019

MERCK: New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care

Press release submission | Aug 18, 2018

MERCK: Healthy Interactions and Merck Announce Launch of Digital Health Platform Designed to Enhance Patient Engagement in Diabetes Management

Carol Ostrow | May 16, 2018

FDA accepts two new drug applications for Merck HIV-1 therapy

Marian Johns | Jan 17, 2018

FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer

Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval

Carol Ostrow | Oct 15, 2017

Merck KGaA aims raise awareness, boost support for unpaid caregivers

Carol Ostrow | Oct 1, 2017

Merck to host meeting on third-quarter performance

Trending

Patient Daily | Aug 12, 2025

Capitol Breathe Free Otolaryngologist on air quality and pollution: ‘These are common triggers for sinus inflammation and sinus infections’

Patient Daily | Aug 14, 2025

Founder of Policy Candy: '340B must see comprehensive reforms'

+ Pharmaceuticals

Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’

+ Pharmaceuticals

Patient Daily | Aug 14, 2025

PhRMA COO on 340B: 'Hidden tax on patients, taxpayers & employers'